Clinical Trial Update: Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing AR-12286 with latanoprost in patients with elevated intraocular pressure due to glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• AR-12286
• Latanoprost (Latanoprost)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Glaucoma | Phase 2 | Status: COMPLETED